Three-dimensional quantitative structure–activity relationship (3 D-QSAR) and docking studies on (benzothiazole-2-yl) acetonitrile derivatives as c-Jun N-terminal kinase-3 (JNK3) inhibitors
We have developed a 3D-QSAR model and performed a series of structural studies on a series of benzothiazole-2yl acetonitrile derivatives with high inhibition activity towards c-Jun N-terminal kinase-3. The results were compared with experimental structure-based studies using JNK3 crystal structure t...
Saved in:
Published in | Bioorganic & medicinal chemistry letters Vol. 16; no. 22; pp. 5917 - 5925 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Oxford
Elsevier Ltd
15.11.2006
Elsevier |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | We have developed a 3D-QSAR model and performed a series of structural studies on a series of benzothiazole-2yl acetonitrile derivatives with high inhibition activity towards c-Jun N-terminal kinase-3. The results were compared with experimental structure-based studies using JNK3 crystal structure to gain insight into the structural requirements for inhibitory activity of this class.
Three-dimensional quantitative structure–activity relationship (3D-QSAR) models were developed for 44 (benzothiazole-2-yl) acetonitrile derivatives, inhibiting c-Jun N-terminal kinase-3 (JNK3). It includes molecular field analysis (MFA) and receptor surface analysis (RSA). The QSAR model was developed using 34 compounds and its predictive ability was assessed using a test set of 10 compounds. The predictive 3D-QSAR models have conventional
r
2 values of 0.849 and 0.766 for MFA and RSA, respectively; while the cross-validated coefficient
r
cv
2
values of 0.616 and 0.605 for MFA and RSA, respectively. The results of the QSAR model were further compared with a structure-based analysis using docking studies with crystal structure of JNK3. Ligands bind in the ATP pocket and the hydrogen bond with GLN155 was found to be crucial for selectivity among other kinases. The results of 3D-QSAR and docking studies validate each other and hence, the combination of both methodologies provides a powerful tool directed to the design of novel and selective JNK3 inhibitors. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0960-894X 1464-3405 |
DOI: | 10.1016/j.bmcl.2006.06.039 |